Lauren White
Director of Finance/CFO chez IMMUNOGEN, INC.
Profil
Lauren A.
White is currently the Chief Financial Officer & Senior Vice President at ImmunoGen, Inc. Prior to this, she was the Treasurer, Chief Financial & Accounting Officer at C4 Therapeutics, Inc. from 2021 to 2023.
Before that, she was the VP, Global Head-Business Planning & Analysis at Novartis Institutes for Biomedical Research, Inc. Ms. White holds an MBA from Harvard Business School and an undergraduate degree from Wallace E Carroll School of Management.
Postes actifs de Lauren White
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOGEN, INC. | Director of Finance/CFO | 18/09/2023 |
Anciens postes connus de Lauren White
| Sociétés | Poste | Fin |
|---|---|---|
| C4 THERAPEUTICS, INC. | Director of Finance/CFO | 15/09/2023 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Lauren White
| Harvard Business School | Masters Business Admin |
| Wallace E Carroll School of Management | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IMMUNOGEN, INC. | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
